ARCHIVED Skip navigation.PDF Version     To Publications Page     To Home Page


South Florida High Intensity Drug Trafficking Area Drug Market Analysis 2010

Publication Date: May 2010

Document ID: 2010-R0813-030Cover image of South Florida HIDTA Drug Market Analysis 2010.

Archived on: September 1, 2011. This document may contain dated information. It remains available to provide access to historical materials.

This assessment is an outgrowth of a partnership between the NDIC and HIDTA Program for preparation of annual assessments depicting drug trafficking trends and developments in HIDTA Program areas. The report has been coordinated with the HIDTA, is limited in scope to HIDTA jurisdictional boundaries, and draws upon a wide variety of sources within those boundaries.

Your questions, comments, and suggestions for future subjects are welcome at any time. Addresses are provided at the end of the page.


Strategic Drug Threat Developments

HIDTA Overview

Drug Threat Overview

Drug Trafficking Organizations




Drug-Related Crime


Illicit Finance




List of Figures

Figure 1. South Florida High Intensity Drug Trafficking Area
Figure 2. South Florida HIDTA Transportation Corridors

List of Tables

Table 1. South Florida HIDTA Initiative Seizures, by Drug, in Kilograms, 2009
Table 2. Indoor Cannabis Cultivation Sites Seized and Plants Eradicated in South Florida HIDTA Counties, 2005-2009

Strategic Drug Threat Developments

The most significant drug threats to the South Florida High Intensity Drug Trafficking Area (HIDTA) region are the diversion, distribution, and abuse of controlled prescription drugs (CPDs), the distribution and abuse of cocaine, and indoor cannabis cultivation and subsequent distribution and abuse of marijuana. Rising heroin availability and abuse pose a serious threat as well. Local methamphetamine production is an emerging threat to the region. In addition, the South Florida HIDTA region is a major venue for laundering and moving billions of dollars in illicit drug proceeds, particularly through the Colombian Black Market Peso Exchange (BMPE) and bulk cash smuggling.

The following are significant strategic drug threat developments in the South Florida HIDTA region:

To Top      To Contents


National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901-1622

Tel. (814) 532-4601
FAX (814) 532-4690
E-mail NDIC.Contacts@usdoj.gov


Office of Policy and Interagency Affairs
U.S. Department of Justice
Robert F. Kennedy Building, Room 3341
950 Pennsylvania Avenue, NW
Washington, D.C. 20530-2000

Telephone: (202) 532-4040
FAX (202) 514-4252

Web Addresses

ADNET:  http://ndicosa.adnet.sgov.gov
DOJ:  http://www.justice.gov/archive/ndic/
LEO:  https://www.leo.gov/http://leowcs.leopriv.gov/lesig/archive/ndic/index.htm
RISS:  ndic.riss.net


a. Opioid pain relievers include codeine, fentanyl (Duragesic, Actiq), hydromorphone (Dilaudid), meperidine (Demerol), morphine (MS Contin), oxycodone (OxyContin, Roxicodone), methadone (Dolophine), and hydrocodone combinations (Vicodin, Lortab, and Lorcet).
b. Pseudoephedrine smurfing is a method used by some methamphetamine traffickers to acquire large quantities of precursor chemicals. Methamphetamine producers purchase the chemicals in quantities at or below the legal thresholds from multiple retail locations. Methamphetamine producers often enlist the assistance of several friends or associates in smurfing operations to increase the speed of production and the quantity of chemical acquired.

Questions and comments may be directed to Southeast/Florida/Caribbean Unit, Regional Threat Analysis Branch through NDIC.Contacts@usdoj.gov.

To Top     To Contents     To Next Page

To Publications Page     To Home Page


End of page.